Clinical trial Recruiting at 4 sites Interventional Ages 18 and up

Improving recruitment for stroke rehabilitation trials in Canada

Official title: Optimizing Recruitment to Drive Equitable Research Opportunity in Stroke Rehabilitation in Canada - The ORDER Pilot Study

Run by McMaster University · NCT06576089 · Data updated 2026-11-12

This study is trying out a new way to recruit women and people with aphasia for stroke rehabilitation trials in Canada by using videos and leaflets to see if it helps them join these important studies.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorMcMaster University
Academic / other
Locations5 sites (Calgary, Alberta and 4 other locations)
StatusRecruiting
StartedJune 16, 2025
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedSeptember 26, 2025
Trial IDNCT06576089 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who have experienced a primary ischemic anterior circulation stroke and are within 5 to 8 weeks post-stroke.

Probably not a fit

Patients with a pre-stroke modified Rankin score of 2 or higher, or those with significant comorbidities that limit their ability to participate in rehabilitation, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot project aims to enhance recruitment for stroke rehabilitation trials by developing a women-centered and aphasia-friendly approach. It will assess the feasibility of using a video and leaflet to support traditional recruitment methods, focusing on underrepresented groups such as women and individuals with aphasia. The study will also explore barriers and facilitators to participation in stroke recovery trials and provide preliminary estimates of the effectiveness of the new recruitment strategy compared to standard methods. The research will be conducted across multiple sites in Canada.

Why it matters

Potential benefit: If successful, this approach could lead to more equitable representation in stroke rehabilitation research, ultimately improving treatment outcomes for diverse patient populations.

How similar studies have gone: While there have been studies focusing on recruitment strategies in clinical trials, this specific approach targeting women and individuals with aphasia in stroke rehabilitation is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Primary ischemic anterior circulation stroke
2. Age ≥18 years
3. ≥5 days but \<8 weeks after stroke on the date of medication (Maraviroc or placebo) start
4. Hemiparesis requiring inpatient rehabilitation
5. Assistance available for daily rehabilitation training practice and for transportation when needed
6. Adequate language skills to understand Informed Consent and retain information during daily therapies
7. At least one of the following: some shoulder abduction with gravity eliminated and visible extension in two or more digits OR visible hip flexion or extension

Exclusion Criteria:

1. Pre-stroke modified Rankin score ≥2
2. Limited resources or illness that will not enable a return to living outside of a facility
3. History of dementia
4. History of hepatitis or elevated hepatic transaminases or bilirubin
5. History of renal insufficiency or creatinine clearance (eGFR) \<60mL / min / 1.73m2
6. Cancer or other chronic illness that makes 1-year survival unlikely or will detract from the ability to carry out exercise and skills practice
7. Existing pre-stroke serious disabling disease (e.g., Parkinson's disease, severe traumatic brain injury, amputation)
8. Seizure related to stroke
9. Acute or chronic epilepsy
10. Currently taking any of the following anticonvulsant medications: Carbamazepine, Phenobarbital, Phenytoin
11. Pregnant, breastfeeding, or positive test for pregnancy at baseline
12. Women of childbearing potential who are not using one highly effective form of contraception or two forms of effective contraception
13. Known HIV positivity
14. Currently taking any of the following antifungal and/or antibacterial medications: Ketoconazole, Itraconazole, Voriconazole, Rifampin, Clarithromycin, Rifabutin + Protease Inhibitor
15. Currently taking St. John's Wort

Where it's running

  • University of Calgary & Foothills Medical Centre
    Calgary, Alberta, Canada
    Recruiting
  • University of British Columbia & GF Strong Rehabilitation Centre
    Vancouver, British Columbia, Canada
    Recruiting
  • Dalhousie University
    Halifax, Nova Scotia, Canada
    Recruiting
  • Parkwood Institute
    London, Ontario, Canada
    Recruiting
  • Toronto Rehabilitation Institute - University Health Network
    Toronto, Ontario, Canada
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.